Blueshift Asset Management, LLC Novo Cure LTD Transaction History

Blueshift Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $369,885 - $619,447	-3,184 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$130.4 - $225.58 $8,345 - $14,437	-64 Reduced 1.97%	3,184 $706,000
Q1 2021 May 06, 2021	BUY	$124.11 - $190.17 $403,109 - $617,672	3,248 New	3,248 $429,000
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $236,347 - $353,961	-5,598 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$31.96 - $56.12 $178,912 - $314,159	5,598 New	5,598 $270,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.